TickerFactsScreenerDevelopers

BeOne Medicines Ltd. (ONC) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $3.93M2014: $13.90M2015: $17.87M2016: $87.51M2017: $239.60M2018: $712.94M2019: $618.01M2020: $1.38B2021: $4.38B2022: $3.87B2023: $3.17B2024: $2.63B2025: $4.55B$4.55B
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$4.55B+73.1%
2024$2.63B-17.2%
2023$3.17B-18.0%
2022$3.87B-11.6%
2021$4.38B+216.6%
2020$1.38B+123.6%
2019$618.01M-13.3%
2018$712.94M+197.6%
2017$239.60M+173.8%
2016$87.51M+389.8%
2015$17.87M+28.6%
2014$13.90M+254.0%
2013$3.93M—